Speciation's roots?

A normal Arabidopsis plant (center), surrounded by different hybrids formed by crossing two healthy plants. Credit: Kirsten Bomblies and Detlef Weigel, Max Planck Institute for Developmental Biology, Tübingen" />A normal Arabidopsis plant (center), surrounded by different hybrids formed by crossing two healthy plants. Credit: Kirsten Bomblies and Detlef Weigel, Max Planck

Written byAlla Katsnelson
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

About four years ago, Janne Lempe, then a graduate student at the Max Planck Institute for Developmental Biology in Tübingen, was hard at work on a series of experiments on the genetic regulation of flowering time in Arabidopsis thaliana. She crossed two strains, chosen for their difference in flowering time, and set off to the greenhouse to leave the seeds to grow.

Researchers generally raise Arabidopsis at 23° C, but with the lab's main greenhouse full, Lempe plunked her experiment into the 16° C greenhouse next door. A few weeks on, her seedlings had produced stunted, stumpy, deformed versions of the hearty white-flowered weeds she was expecting. Her plants were not only unusually small, but their leaves were also covered in necrotic brown spots, and they'd failed to flower.

Lempe's two starting strains, UK1 and UK3, were perfectly normal. So why would their offspring be sick? Right away, says Detlef ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies